Cochlear Ltd - Asset Resilience Ratio

Latest as of June 2025: 9.76%

Cochlear Ltd (COH) has an Asset Resilience Ratio of 9.76% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how liquid is Cochlear Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

AU$275.70 Million
≈ $195.08 Million USD Cash + Short-term Investments

Total Assets

AU$2.83 Billion
≈ $2.00 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2010–2025)

This chart shows how Cochlear Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Cochlear Ltd total assets.

Liquid Assets Composition Over Time

This chart breaks down Cochlear Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore COH strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents AU$275.70 Million 9.76%
Short-term Investments AU$0.00 0%
Total Liquid Assets AU$275.70 Million 9.76%

Asset Resilience Insights

  • Limited Liquidity: Cochlear Ltd maintains only 9.76% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Cochlear Ltd Industry Peers by Asset Resilience Ratio

Compare Cochlear Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Medtronic plc
SA:MDTC34
Medical Devices 7.82%
Demant A/S
CO:DEMANT
Medical Devices -2.59%
Medartis Holding AG
SW:MED
Medical Devices 0.00%
Xiangyu Medical Co. Ltd. A
SHG:688626
Medical Devices 1.53%
L&C Bio Co. Ltd
KQ:290650
Medical Devices 2.14%
Beijing Chunlizhengda Medical Instruments Co Ltd
SHG:688236
Medical Devices 25.01%
Mediantechn
PA:ALMDT
Medical Devices 0.45%
Emvision Medical Devices Ltd
AU:EMV
Medical Devices 0.06%

Annual Asset Resilience Ratio for Cochlear Ltd (2010–2025)

The table below shows the annual Asset Resilience Ratio data for Cochlear Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-06-30 9.76% AU$275.70 Million
≈ $195.08 Million
AU$2.83 Billion
≈ $2.00 Billion
-12.69pp
2024-06-30 22.45% AU$616.30 Million
≈ $436.07 Million
AU$2.75 Billion
≈ $1.94 Billion
-2.71pp
2023-06-30 25.16% AU$646.30 Million
≈ $457.30 Million
AU$2.57 Billion
≈ $1.82 Billion
-3.16pp
2022-06-30 28.32% AU$698.10 Million
≈ $493.95 Million
AU$2.47 Billion
≈ $1.74 Billion
+2.07pp
2021-06-30 26.25% AU$636.90 Million
≈ $450.65 Million
AU$2.43 Billion
≈ $1.72 Billion
-9.75pp
2020-06-30 36.00% AU$930.00 Million
≈ $658.03 Million
AU$2.58 Billion
≈ $1.83 Billion
+3.84pp
2019-06-30 32.16% AU$443.60 Million
≈ $313.88 Million
AU$1.38 Billion
≈ $975.87 Million
+26.53pp
2018-06-30 5.64% AU$65.20 Million
≈ $46.13 Million
AU$1.16 Billion
≈ $818.58 Million
-3.87pp
2017-06-30 9.50% AU$107.97 Million
≈ $76.40 Million
AU$1.14 Billion
≈ $804.00 Million
+8.31pp
2016-06-30 1.20% AU$11.45 Million
≈ $8.10 Million
AU$957.36 Million
≈ $677.40 Million
+0.76pp
2015-06-30 0.44% AU$3.85 Million
≈ $2.73 Million
AU$875.40 Million
≈ $619.40 Million
+0.41pp
2010-06-30 0.03% AU$204.00K
≈ $144.34K
AU$751.72 Million
≈ $531.89 Million
--
pp = percentage points

About Cochlear Ltd

AU:COH Australia Medical Devices
Market Cap
$6.20 Billion
AU$8.76 Billion AUD
Market Cap Rank
#3121 Global
#69 in Australia
Share Price
AU$133.90
Change (1 day)
-1.83%
52-Week Range
AU$90.00 - AU$296.20
All Time High
AU$345.53
About

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor… Read more